M&A Update – March 10

– SSYS received an unsolicited non-binding indicative offer from NNDM at $18.00 cash per share
– VVNT / NRG deal closed
– MYOV / Sumitovant Biopharma deal closed
– MLVF / FRBA filed PREM14a, votes Apr 28, closing Q2 2023
– BKI / ICE / FTC to block merger, ICE fully confident in its position and looks forward to presenting it in court, closing Q3 or Q4